Inventor · disambiguated record
Jacky Vonderscher
Also filed as: VONDERSCHER JACKY
14 granted patents·20 pending applications·353 citations·filing 1993–2024
94Inventor score
Top patents by PatentIndex Score
34 records- 0193US5932243AGalenical formulationsNOVARTIS AG·Filed 1997·Granted Aug 3, 1999·115 cites·7 claims
- 0292US6420355B2Pharmaceutical compositions containing cyclosporinsNOVARTIS AG·Filed 2001·Granted Jul 16, 2002·36 cites·16 claims
- 0389US6844459B2Pharmaceutical CompositionNOVARTIS AG·Filed 2003·Granted Jan 18, 2005·18 cites·20 claims
- 0489US6306900B1Enteric coated pharmaceutical compositionsNOVARTIS AG·Filed 2000·Granted Oct 23, 2001·31 cites·14 claims
- 0588US6262022B1Pharmaceutical compositions containing cyclosporin as the active agentNOVARTIS AG·Filed 2000·Granted Jul 17, 2001·16 cites·12 claims
- 0688US6258808B1Pharmaceutical compositionNOVARTIS AG·Filed 2000·Granted Jul 10, 2001·17 cites·8 claims
- 0785US12030861B1L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid and various forms thereofENYO PHARMA·Filed 2023·Granted Jul 9, 2024·2 cites·48 claims
- 0884US6565859B1Galenical formulationsNOVARTIS AG·Filed 2000·Granted May 20, 2003·13 cites·7 claims
- 0982US6025391AEnteric-coated pharmaceutical compositions of mycophenolateNOVARTIS AG·Filed 1997·Granted Feb 15, 2000·43 cites·11 claims
- 1076US6172107B1Entric-coated pharmaceutical compositionsNOVARTIS AG·Filed 1999·Granted Jan 9, 2001·30 cites·8 claims
- 1172US7205279B2Pharmaceutical compositionsNOVARTIS AG·Filed 2000·Granted Apr 17, 2007·2 cites·4 claims
- 1266US2025019358A1L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid and various forms thereofENYO PHARMA·Filed 2024·Application pending·0 cites
- 1364US7025975B2Galenical formulationsNOVARTIS AG·Filed 2004·Granted Apr 11, 2006·1 cites·8 claims
- 1464US2007208075A1Pharmaceutical compositionsCOTTENS SYLVAIN·Filed 2007·Application pending·0 cites
- 1563US5393738APharmaceutical compositions containing octreotide and excipients for oral or rectal administrationSANDOZ LTD·Filed 1993·Granted Feb 28, 1995·29 cites·27 claims
- 1660US2003166517A1Galenical formulationsFiled 2003·Application pending·0 cites
- 1759US2003104990A1Pharmaceutical compositionFiled 2002·Application pending·0 cites
- 1857US2001036918A1Pharmaceutical compositionFiled 2001·Application pending·0 cites
- 1956US2025019370A1L-lysine salt of 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid and various forms thereofENYO PHARMA·Filed 2024·Application pending·0 cites
- 2052US2007218513A1Differentially Expressed Genes Related to Coronary Artery DiseaseNOVARTIS AG·Filed 2004·Application pending·0 cites
- 2152US2023165853A1Method for treating chronic kidney diseasesENYO PHARMA·Filed 2022·Application pending·0 cites
- 2251US2024100125A1Synergistic effect of a fxr agonist and ifn for the treatment of hbv infectionENYO PHARMA·Filed 2022·Application pending·0 cites
- 2351US2023321033A1Thiophen compounds for use in the treatment of renal fibrosisENYO PHARMA·Filed 2021·Application pending·0 cites
- 2450US8609812B2Use of β-2-microglobulin to assess glomerular alterations and damage in the kidneyMAURER GERARD·Filed 2008·Granted Dec 17, 2013·0 cites·7 claims
- 2550US2024156778A1Thiophene derivatives for use in treating portal inflammation and fibrosisENYO PHARMA·Filed 2020·Application pending·0 cites
- 2648US2024002370A1Pyrrole-type compounds and uses thereof for treating viral infectionsENYO PHARMA·Filed 2021·Application pending·0 cites
- 2747US2002165134A1Pharmaceutical compositions containing cyclosporinsFiled 2002·Application pending·0 cites
- 2846US2013040882A1Use of fibroblast growth factor fragmentsNOVARTIS AG·Filed 2012·Application pending·0 cites
- 2946US2009093398A1Use of Fibroblast Growth Factor FragmentsBOLLEKENS JACQUES·Filed 2004·Application pending·0 cites
- 3044US2022313690A1Synergistic effect of eyp001 and ifn for the treatment of hbv infectionENYO PHARMA·Filed 2020·Application pending·0 cites
- 3144US2007238124A1Differentially expressed genes related to coronary artery diseaseCHIBOUT SALAH D·Filed 2007·Application pending·0 cites
- 3243US2022241376A1Method for decreasing adverse-effects of interferonENYO PHARMA·Filed 2020·Application pending·0 cites
- 3340US2012028896A1Use of fibroblast growth factor fragmentsBOLLEKENS JACQUES·Filed 2011·Application pending·0 cites
- 3439US2014171335A1Predictive renal safety biomarkers and biomarker signatures to monitor kidney functionMAURER GERARD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jacky Vonderscher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →